| |
| |
|
| Insider
Information: |
Mulroy Dennis |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
6,031 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$56,070 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,031 |
|
|
| Total
Value |
$56,070 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2020-05-29 |
5,067 |
2018-10-15 |
0 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
|
2024-01-30 |
964 |
2021-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANAB |
Anaptysbio Inc |
Chief Financial Officer |
• – – |
2021-11-15 |
4 |
A |
$22.03 |
$21,237 |
D/D |
964 |
964 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Chief Financial Officer |
• – – |
2023-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
6,964 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Chief Financial Officer |
• – – |
2023-09-14 |
4 |
AS |
$19.48 |
$41,005 |
D/D |
(2,105) |
4,859 |
0 |
% |
|
| ANAB |
Anaptysbio Inc |
Chief Financial Officer |
• – – |
2023-09-18 |
4 |
AS |
$19.32 |
$75,237 |
D/D |
(3,895) |
964 |
0 |
% |
|
| ANAB |
Anaptysbio Inc |
Chief Financial Officer |
• – – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,245 |
6,209 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Chief Financial Officer |
• – – |
2024-01-08 |
4 |
S |
$21.81 |
$47,546 |
D/D |
(2,180) |
4,029 |
0 |
% |
|
| ANAB |
Anaptysbio Inc |
CHIEF FINANCIAL OFFICER |
• – – |
2024-01-30 |
4 |
AS |
$23.63 |
$72,425 |
D/D |
(3,065) |
964 |
0 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2018-10-15 |
4 |
A |
$13.81 |
$304 |
D/D |
22 |
522 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2018-10-31 |
4 |
A |
$13.86 |
$305 |
D/D |
22 |
544 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2018-11-15 |
4 |
A |
$12.67 |
$304 |
D/D |
24 |
568 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2018-11-30 |
4 |
A |
$12.30 |
$320 |
D/D |
26 |
594 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2018-12-14 |
4 |
A |
$10.88 |
$305 |
D/D |
28 |
622 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2018-12-31 |
4 |
A |
$8.02 |
$313 |
D/D |
39 |
661 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-01-15 |
4 |
A |
$5.74 |
$1,814 |
D/D |
316 |
977 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-01-31 |
4 |
A |
$5.13 |
$323 |
D/D |
63 |
1,040 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-02-15 |
4 |
A |
$5.30 |
$318 |
D/D |
60 |
1,100 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-02-28 |
4 |
A |
$4.85 |
$315 |
D/D |
65 |
1,165 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-03-15 |
4 |
A |
$6.49 |
$318 |
D/D |
49 |
1,214 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-03-29 |
4 |
A |
$5.47 |
$323 |
D/D |
59 |
1,273 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-04-15 |
4 |
A |
$6.09 |
$1,589 |
D/D |
261 |
1,534 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-04-30 |
4 |
A |
$6.84 |
$1,594 |
D/D |
233 |
1,767 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-05-15 |
4 |
A |
$5.58 |
$1,590 |
D/D |
285 |
2,052 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-05-31 |
4 |
A |
$4.58 |
$1,589 |
D/D |
347 |
2,399 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-06-14 |
4 |
A |
$8.25 |
$1,592 |
D/D |
193 |
2,592 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-06-28 |
4 |
A |
$7.86 |
$1,588 |
D/D |
202 |
2,794 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
